<style face="normal" font="default" size="100%">Midlife opportunities: Firm age and the value of isomorphic alliance strategies in biotech IPOs</style>

Drupal-Biblio

13

<style face="normal" font="default" size="100%">Midlife opportunities: Firm age and the value of isomorphic alliance strategies in biotech IPOs</style>

Drupal-Biblio

13

<style face="normal" font="default" size="100%">Strategic isomorphism, legitimacy & IPO performance.</style>